Pharmaceutical giant Pfizer has raised its full-year sales estimates for the COVID-19 vaccine to $45 billion.
In the last quarter the company’s total sales reached almost $26 billion with $10 billion of that due to the vaccine.
Over half of the Americans that have had a jab received the codeveloped Pfizer and BioNTech version.
6265662534001businessfblink
0 Comments